![]() |
|||||||||||||||||
![]() |
|||||||||||||||||
![]() ![]() ![]() |
![]() |
|
|||||||||||||||
![]() |
![]() |
MATERIAL SAFETY DATA SHEET - INFECTIOUS SUBSTANCES SECTION I - INFECTIOUS AGENT NAME: Streptococcus pneumoniae SYNONYM OR CROSS REFERENCE: Pneumococcus, Diplococcus, Pneumococcal pneumonia CHARACTERISTICS: Gram-positive diplococci, alpha hemolysis on blood agar, no specific group antigen, facultatively anaerobic, lancet-shaped or in chains, more than 90 serotypes SECTION II - HEALTH HAZARD PATHOGENICITY: Sudden onset with shaking chill, pleural pain, dyspnea, a cough productive of rusty sputum and leukocytosis; clinical features include pneumonia, bacteremia, otitis media, meningitis, sinusitis, peritonitis and arthritis; onset may be less abrupt in elderly requiring x-rays for diagnosis; in infants, vomiting and convulsions may be initial manifestations; important cause of death in infants and elderly; 5-10% fatality with antimicrobial therapy, but 20-40% among patients with underlying disease; neurologic sequelae and/or learning disabilities can occur in meningitis patients EPIDEMIOLOGY: Continuing endemicity, particularly in infancy, old age and alcoholics; more frequent in industrial cities and lower socio-economic groups; occurs in all climates and seasons; incidence is highest in winter and spring in temperate zones; usually sporadic in North America but may occur in epidemics in closed populations
HOST RANGE: Humans INFECTIOUS DOSE: Not known MODE OF TRANSMISSION: By droplet spread; by direct oral contact; indirectly through articles freshly soiled with respiratory discharges; person-to-person transmission of the organisms is common, but illness among casual contacts and attendants is infrequent INCUBATION PERIOD: Not well determined COMMUNICABILITY: Communicable until discharges of mouth and nose no longer contain virulent pneumococci in significant numbers; penicillin renders patient non-infectious within 24-48 hours; many persons are carriers; risk of infection following contact with carrier or infected person low, except in institutional settings SECTION III - DISSEMINATION RESERVOIR: Humans; pneumococci are commonly found in the upper respiratory tract of healthy persons throughout the world ZOONOSIS: None VECTORS: None SECTION IV - VIABILITY DRUG SUSCEPTIBILITY: Sensitive to penicillin and erythromycin DRUG RESISTANCE: High level of resistance to penicillin; resistance to other therapeutic agents such as TMP/SMX, erythromycin, tetracycline, chloramphenicol, ceftriaxone, and cefotaxime SUSCEPTIBILITY TO DISINFECTANTS: Susceptible to many disinfectants - 1% sodium hypochlorite, 70% ethanol, 2% glutaraldehyde, formaldehyde, iodines PHYSICAL INACTIVATION: Sensitive to moist heat (121° C for at least 15 min) and dry heat (160-170° C for at least 1 hour) SURVIVAL OUTSIDE HOST: Mouse carcass - 180-270 days; Dust - up to 25 days; Glass - 1-11 days; Sputum at room temperature - 7 days; Gauze 2-15 days SECTION V - MEDICAL SURVEILLANCE: Monitor for symptoms of infection; confirm bacteriologically FIRST AID/TREATMENT: Penicillin G, administered parenterally (erythromycin for those hypersensitive to penicillin) IMMUNIZATION: Polyvalent vaccine containing capsular polysaccharides for those at high risk of fatal infection (vaccine should be given only once to adults to avoid systemic reactions to a second dose); vaccine is less effective in those under 2 years of age PROPHYLAXIS: Penicillin treatment SECTION VI - LABORATORY HAZARDS LABORATORY-ACQUIRED INFECTIONS: 78 recorded cases of Streptococcus spp. with 4 deaths up to 1976; 5th most common laboratory-acquired infection SOURCES/SPECIMENS: Sputum, blood, respiratory secretions, throat swabs PRIMARY HAZARDS: Inhalation of infectious aerosols; direct contact of mucous membranes; accidental parenteral inoculation SPECIAL HAZARDS: None SECTION VII - RECOMMENDED PRECAUTIONS CONTAINMENT REQUIREMENTS: Biosafety level 2 practices, containment equipment and facilities for all activities involving known or potentially infected clinical materials or cultures; animal biosafety level 2 facilities for studies utilizing infected animals PROTECTIVE CLOTHING: Laboratory coat; gloves when contact with infectious materials is unavoidable OTHER PRECAUTIONS: None SECTION VIII - HANDLING INFORMATION SPILLS: Allow aerosols to settle; wearing protective clothing, gently cover spill with absorbent paper towel and apply 1% sodium hypochlorite, starting at perimeter and working towards the centre; allow sufficient contact time (30 min) before clean up DISPOSAL: Decontaminate before disposal; steam sterilization, chemical disinfection, incineration STORAGE: In sealed containers that are appropriately labelled SECTION IX - MISCELLANEOUS INFORMATION Date prepared: May, 2001 Prepared by: Office of Laboratory Security, PHAC Although the information, opinions and recommendations contained in this Material Safety Data Sheet are compiled from sources believed to be reliable, we accept no responsibility for the accuracy, sufficiency, or reliability or for any loss or injury resulting from the use of the information. Newly discovered hazards are frequent and this information may not be completely up to date. Copyright © [Material Safety Data Sheets - Index]
|
![]() |
|||
![]() |
Last Updated: 2001-09-25 | ![]() |